TipRanks
Go Ultimate55% OFF
PC:WUGEN

Wugen Inc: Valuation, Funding & Investors

Wugen Inc., headquartered in St. Louis, Missouri, specializes in developing off-the-shelf allogeneic CAR-T cell therapies derived from healthy donor cells. The company focuses on addressing unmet needs in hematologic malignancies through its proprietary CAR-T platform, aiming to provide innovative solutions in the field of cancer treatment.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$115M
Total Funding Rounds
1
Latest Funding Amount
$115M
Latest Funding Round
Investment

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Sep 18, 2025Investment$115.00M―

Investors

Similar Companies

A snapshot of private companies similar to Wugen Inc, helping you discover and navigate related company profiles.

Related News and Analysis